SCHEMBL4906150

SCHEMBL4906150

C[Si](C)(C)c1cccc(-c2ccc(-c3cccc([Si](C)(C)C)c3)nc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 3/20 0.59
HSD17B2 P37059 3/20 0.59
IRAK4 Q9NWZ3 2/20 0.40
MAP4K4 O95819 3/20 0.40
TRPV3 Q8NET8 2/20 0.39
HPGDS O60760 2/20 0.39
KDM1A O60341 4/20 0.37
WNT3A P56704 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2A6 P11509 1/20 0.35
MAOB P27338 1/20 0.34
PLK4 O00444 1/20 0.33
DCLK1 O15075 1/20 0.33
ROCK2 O75116 1/20 0.33
PRKD3 O94806 1/20 0.33
PAK4 O96013 1/20 0.33
CHEK2 O96017 1/20 0.33
INSR P06213 1/20 0.33
CDK1 P06493 1/20 0.33
FES P07332 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31754774 0.87 HSD17B1 (0.43) HSD17B1HSD17B2TRPV3HPGDSKDM1A
SCHEMBL13765154 0.87 HSD17B1 (0.43) HSD17B1HSD17B2TRPV3HPGDSKDM1A
SCHEMBL18069588 0.84 CYP3A4 (0.53) HSD17B1HSD17B2TRPV3KDM1ACYP3A4
SCHEMBL16405288 0.77 HSD17B1 (0.45) HSD17B1HSD17B2KDM1ACYP3A4
SCHEMBL12957239 0.77 HSD17B1 (0.67) HSD17B1HSD17B2IRAK4MAP4K4HPGDS
SCHEMBL24134487 0.77 HSD17B1 (0.38) HSD17B1HSD17B2TRPV3HPGDSKDM1A
SCHEMBL17754240 0.76 HPGDS (0.47) HSD17B1HSD17B2HPGDSCYP3A4
SCHEMBL4402515 0.76 HSD17B1 (0.61) HSD17B1HSD17B2MAP4K4KDM1ACYP3A4
SCHEMBL26548178 0.76 CYP11B1 (0.45) HSD17B1HSD17B2CYP3A4
SCHEMBL12973163 0.76 HSD17B1 (0.59) HSD17B1HSD17B2MAP4K4KDM1ACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9078330-B2 Highly branched dendrimers ISIS INNOVATION LIMITED (GB) 2015-07-07 US disclosed
US-20080211391-A1 Highly Branched Dendrimers CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080211391-A1 Highly Branched Dendrimers ITGB1, PICALM, BTN3A1 HSD17B1 829/4885HSD17B2 1602/4885IRAK4 1079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.